News

Weight-loss patients taking Zepbound forced to switch to Wegovy after drop in coverage

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Could GLP-1 Drugs Potentially Help Treat Cancer? 1 Promising Study Suggests They Might

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Hairstylist Tim Bo Mack Recalls ‘Desperate’ Dieting Fails Before Trying a GLP-1: ‘I’m Really Living Now’ (Exclusive)

Texas hairstylist Tim Bo Mack opened up to PEOPLE about his years-long struggle to lose weight. He finally found success ...

Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound

An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki's ...

Eli Lilly’s Obesity Pill Appears to Work as Well as Injected GLP-1s

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and Ozempic for weight loss and lowering blood sugar.